illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Biocartis Group
Company logo

Biocartis Group | Sustainability Performance

https://www.biocartisgroupnv.be
Linkedin

This organization develops and commercializes molecular diagnostic solutions, aiming to provide rapid and accurate results for oncology and infectious diseases through its innovative platform.

2007

Belgium

501 - 1,000 employees

Medical Device

$25M - 100M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#8258
Overall
#114
in Belgium
#122
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Environmental
Energy consumption
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Fagron

Belgium, Hospital & Health Care, Pharmaceuticals


Company logo
Realco

Belgium, Hospital & Health Care, Biotechnology


Company logo
Biotalys

Belgium, Hospital & Health Care, Biotechnology

Renewable energy

39% 2022
Laggard

Market cap

24.9M $, 2026▲0% YoY

Revenue

64.3M $, 2022▲15.8% YoY

R&D intensity

66.67% 2022

Renewable electricity

Reveal data for 1 credit
39%2022

Industry rank: 6 out of 175


Total electricity consumption
and % renewables
(MWh, % of consumption)

Industry rank: 6 out of 175

Total electricity

Share of renewable electricity

Industry benchmark

Powered by illuminem and GIST Impact

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

24.9M $, 2026▲0% YoY

Revenue

64.3M $, FY2022▲15.8% YoY

EBITDA

-47.4M $, FY2022▼9.1% YoY

Operating margin

-83% Industry: -136▼55.6% YoY

Revenue & EBITDA

$64.3MFY2022 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-52.8M 2022▼48.5% YoY

Capex

1.1M 2022▼200% YoY

Debt/equity ratio

-4.0 Industry: 1▼NaN% YoY

R&D intensity

66.7%FY2022

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

-71.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.0

▼ 6.3%

2020

0.1

▼ 10.9%

2021

0.1

▲ 2.0%

2022

0.1

2025

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

45%
Independent Directors

5 out of 11 incl. management

Powered by illuminem

Overall score

86

Environment

92

Social

99

Governance

65

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Sustainability employees


Total sustainability employees

4-6


    Available in
    Scale package

    Access
  • Email

  • Email